Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells

被引：10

作者：

Qian, Xu ^{[1
,2
,3
,4
,5
]}

Nie, Xiaobo ^{[6
]}

Wollenberg, Barbara ^{[7
]}

Sudhoff, Holger ^{[8
]}

Kaufmann, Andreas M. ^{[2
,3
,4
,9
]}

Albers, Andreas E. ^{[1
,2
,3
,4
]}

机构：

[1] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] Berlin Inst Hlth, Berlin, Germany

[5] Zhejiang Canc Hosp, Dept Lab Med, Div Mol Diagnost, Hangzhou, Zhejiang, Peoples R China

[6] Henan Univ, Sch Basic Med Sci, Key Lab Receptors Mediated Gene Regulat & Drug Di, Kaifeng, Peoples R China

[7] Univ Hosp Schleswig Holstein, Clin Otorhinolaryngol Head & Neck Surg, Campus Lubeck, Lubeck, Germany

[8] Klinikum Bielefeld, Dept Otorhinolaryngol Head & Neck Surg, Bielefeld, Germany

[9] Charite Univ Med Berlin, Clin Gynecol, Berlin, Germany

来源：

STEM CELLS HETEROGENEITY IN CANCER | 2019年 / 1139卷

关键词：

Head and neck squamous cell carcinoma (HNSCC); Epidermal growth factor receptor (EGFR); Cancer stem cell (CSC); Immunotherapy; Epithelial-to-mesenchymal transition (EMT); Mesenchymal-to-epithelial transition (MET); Aldehyde dehydrogenase I; Immune response; Immune evasion; PD-1; PD-L1; Tumor microenvironment; CSC-directed therapeutic; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM(-LIKE) CELLS; ALDEHYDE DEHYDROGENASE 1; TUMOR-INITIATING CELLS; PUTATIVE MARKER; SELF-RENEWAL; ORAL-CANCER; EXPRESSION; HYPOXIA; PROMOTES;

D O I：

10.1007/978-3-030-14366-4_2

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Current systemic cancer treatment in head and neck squamous cell carcinoma (HNSCC) is moving toward more personalized approaches such as de-escalation protocols human-papilloma-virus dependent HNSCC or application of checkpoint inhibitors. However, these treatments have been challenged by cancer stem cells (CSC), a small population within the bulk tumor, which are leading to treatment failure, tumor recurrence, or metastases. This review will give an overview of the characteristics of HNSCC-CSC. Specifically, the mechanisms by which HNSCC-CSC induce tumor initiation, progression, recurrence, or metastasis will be discussed. Although evidence-based treatment options targeting HNSCC-CSC specifically are still being sought for, they warrant a promise for additional and sustainable treatment options where for HNSCC patients where others have failed.

引用

页码：23 / 40

页数：18

共 103 条

[1] Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
Akalay, Intissar
Janji, Bassam
Hasmim, Meriem
Noman, Muhammad Zaeem
Andre, Fabrice
De Cremoux, Patricia
Bertheau, Philippe
Badoual, Cecile
Vielh, Philippe
Larsen, Annette K.
Sabbah, Michele
Tan, Tuan Zea
Keira, Joan Herr
Hung, Nicole Tsang Ying
Thiery, Jean Paul
Mami-Chouaib, Fathia
Chouaib, Salem
[J]. CANCER RESEARCH, 2013, 73 (08) : 2418 - 2427
[2] Notch signalling in cancer stem cells
Bolos, Victoria
Blanco, Moises
Medina, Vanessa
Aparicio, Guadalupe
Diaz-Prado, Silvia
Grande, Enrique
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01) : 11 - 19
[3] A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma
Bowles, Daniel W.
Keysar, Stephen B.
Eagles, Justin R.
Wang, Guoliang
Glogowska, Magdalena J.
McDermott, Jessica D.
Le, Phuong N.
Gao, Dexiang
Ray, Charles E.
Rochon, Paul J.
Roop, Dennis R.
Tan, Aik-Choon
Serracino, Hilary S.
Jimeno, Antonio
[J]. ORAL ONCOLOGY, 2016, 53 : 74 - 79
[4] Endothelial derived factors inhibit anoikis of head and neck cancer stem cells
Campos, Marcia S.
Neiva, Kathleen G.
Meyers, Kristy A.
Krishnamurthy, Sudha
Noer, Jacques E.
[J]. ORAL ONCOLOGY, 2012, 48 (01) : 26 - 32
[5] TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
Chen, Calvin Yu-Chian
[J]. PLOS ONE, 2011, 6 (01):
[6] Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma
Chen, Chao
Zimmermann, Miriam
Tinhofer, Inge
Kaufmann, Andreas M.
Albers, Andreas E.
[J]. CANCER LETTERS, 2013, 338 (01) : 47 - 56
[7] Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma
Chen, Demeng
Wu, Mansi
Li, Yang
Chang, Insoon
Yuan, Quan
Ekimyan-Salvo, Mari
Deng, Peng
Yu, Bo
Yu, Yongxin
Dong, Jiaqiang
Szymanski, John M.
Ramadoss, Sivakumar
Li, Jiong
Wang, Cun-Yu
[J]. CELL STEM CELL, 2017, 20 (05) : 621 - +
[8] TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma
Chen, Lei
Li, Yi-Cun
Wu, Lei
Yu, Guang-Tao
Zhang, Wen-Feng
Huang, Cong-Fa
Sun, Zhi-Jun
[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (02) : 1337 - 1349
[9] Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0023237]
[10] Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1
Chen, Yu-Chih
Chang, Charn-Jung
Hsu, Han-Shui
Chen, Yi-Wei
Tai, Lung-Kuo
Tseng, Ling-Ming
Chiou, Guang-Yuh
Chang, Shih-Ching
Kao, Shou-Yen
Chiou, Shih-Hwa
Lo, Wen-Liang
[J]. ORAL ONCOLOGY, 2010, 46 (03) : 158 - 165

← 1 2 3 4 5 6 7 8 9 10 →